Vivani Medical Q2 EPS $(0.13) Misses $(0.11) Estimate
Portfolio Pulse from Benzinga Newsdesk
Vivani Medical (NASDAQ:VANI) reported Q2 losses of $(0.13) per share, missing the analyst consensus estimate of $(0.11) by 18.18%. This represents a 18.18% decrease over losses from the same period last year.
August 14, 2023 | 9:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vivani Medical's Q2 earnings per share missed analyst estimates by 18.18%, indicating a larger loss than expected. This could negatively impact investor sentiment.
Vivani Medical's Q2 earnings per share were lower than expected, which could lead to a decrease in the company's stock price in the short term as it indicates the company's performance is not meeting expectations. This could negatively impact investor sentiment and lead to selling pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100